Germany | BCH-RA-DE-46349 | Risk Assessment generated by a regulatory process | Biosafety Clearing-House

Loading...
  |  
BCH-RA-DE-46349-6   |   PDF   |   Print   |  

Risk Assessment generated by a regulatory process (RA)

last updated: 08 Jun 2020
General Information
6786-01-0185 (adv. 42010.0185); Summary of the risk assessment of a deliberate release (field trial) of MON89034, MON88017, NK603, MON89034 x MON88017 and MON89034 x NK603, issued by the German Competent Authority
EN
01 Jun 2007
Risk assessment details
Methodology and points to consider
The execution of this field trial is not expected to have a negative impact on human or animal health, or on the environment.
EN
EN
EN
Adverse effects on human or animal health, or on the environment are not expected
EN
EN
EN
9 field sites in different regions of Germany, details see German LMO/GMO location register (http://apps2.bvl.bund.de/stareg_web/localeSwitch.do?language=en&page=/showflaechen.do?)
EN
PCR-based method, event-specific, submitted with a notification for placing on the market under Regulation (EU) Nr. 1829/2003, available at: http://gmo-crl.jrc.ec.europa.eu/StatusOfDossiers.aspx
EN
Additional information
deliberate release, no placing on the market.
field trial, not for human consumption or for feed purposes

An English summary of the notification including the risk assessment of the notifier is available at the EU WebSNIF internet-page of Joint Research Centre under notification number B/DE/06/185 (http://gmoinfo.jrc.ec.europa.eu/gmp_report.aspx?CurNot=B/DE/06/185)

LMOs of this field trial are notified for placing on the market in the EU for food, feed and processing purposes, too. Further information is available at the internet-page of the European Commission: http://ec.europa.eu/food/dyna/gm_register/index_en.cfm
EN
Loading...